These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17576170)

  • 1. Immunoglobulin somatic hypermutation.
    Teng G; Papavasiliou FN
    Annu Rev Genet; 2007; 41():107-20. PubMed ID: 17576170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cytidine deaminase AIDs in the delivery of error-prone polymerases to immunoglobulin genes.
    Diaz M; Storb U
    DNA Repair (Amst); 2003 May; 2(5):623-7. PubMed ID: 12713818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for Mlh3 in somatic hypermutation.
    Li Z; Peled JU; Zhao C; Svetlanov A; Ronai D; Cohen PE; Scharff MD
    DNA Repair (Amst); 2006 Jun; 5(6):675-82. PubMed ID: 16564751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recruitment of activation induced cytidine deaminase to the immunoglobulin locus by a regulatory element.
    Kim Y; Tian M
    Mol Immunol; 2010 May; 47(9):1860-5. PubMed ID: 20334924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction of AID activity and somatic hypermutation by PARP-1.
    Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
    Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing AID and DNA repair during somatic hypermutation.
    Liu M; Schatz DG
    Trends Immunol; 2009 Apr; 30(4):173-81. PubMed ID: 19303358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemistry of somatic hypermutation.
    Peled JU; Kuang FL; Iglesias-Ussel MD; Roa S; Kalis SL; Goodman MF; Scharff MD
    Annu Rev Immunol; 2008; 26():481-511. PubMed ID: 18304001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic hypermutation: processivity of the cytosine deaminase AID and error-free repair of the resulting uracils.
    Storb U; Shen HM; Nicolae D
    Cell Cycle; 2009 Oct; 8(19):3097-101. PubMed ID: 19738437
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.
    Diaz M; Lawrence C
    Trends Immunol; 2005 Apr; 26(4):215-20. PubMed ID: 15797512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSH6- or PMS2-deficiency causes re-replication in DT40 B cells, but it has little effect on immunoglobulin gene conversion or on repair of AID-generated uracils.
    Campo VA; Patenaude AM; Kaden S; Horb L; Firka D; Jiricny J; Di Noia JM
    Nucleic Acids Res; 2013 Mar; 41(5):3032-46. PubMed ID: 23314153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of isotype switching.
    Stavnezer J; Amemiya CT
    Semin Immunol; 2004 Aug; 16(4):257-75. PubMed ID: 15522624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taming AID mutator activity in somatic hypermutation.
    Qin Y; Meng FL
    Trends Biochem Sci; 2024 Jul; 49(7):622-632. PubMed ID: 38614818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate.
    Arakawa H; Saribasak H; Buerstedde JM
    PLoS Biol; 2004 Jul; 2(7):E179. PubMed ID: 15252444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.
    Budzyńska PM; Kyläniemi MK; Kallonen T; Soikkeli AI; Nera KP; Lassila O; Alinikula J
    Eur J Immunol; 2017 Jun; 47(6):993-1001. PubMed ID: 28301039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of somatic hypermutation.
    Odegard VH; Schatz DG
    Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation patterns at Ig and Non-Ig Loci.
    Steele EJ; Franklin A; Lindley RA
    DNA Repair (Amst); 2024 Jan; 133():103607. PubMed ID: 38056368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations in Somatic Hypermutation Between Sites in IGHV Genes Can Be Explained by Interactions Between AID and/or Polη Hotspots.
    Krantsevich A; Tang C; MacCarthy T
    Front Immunol; 2020; 11():618409. PubMed ID: 33603748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of activation induced deaminase via phosphorylation.
    Basu U; Chaudhuri J; Phan RT; Datta A; Alt FW
    Adv Exp Med Biol; 2007; 596():129-37. PubMed ID: 17338181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.